Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH) announced that the company's employee shareholding platforms, Shanghai Aixiang and Shanghai Aiyun, plan to reduce their holdings of a large amount through trading...
According to the announcement of Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH), the company's employee shareholding platforms, Shanghai Aixiang and Shanghai Aiyun, plan to reduce their holdings of the company's shares by no more than 4.5 million shares through bulk trading, and the proportion of the planned shareholding reduction does not exceed 1.00% of the total share capital of the company. The reduction will be implemented within three months from August 22, 2024.